Check Before You Invest : Innova Captab Ltd

Snapshot

Q.1 Which industry/sub-sector does Innova Captab Ltd belong to?

Innova Captab Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Innova Captab Ltd a good quality company?

Innova Captab Ltd is a average quality company, based on a somewhat consistent 7-year financial track record.

Q.3 Is Innova Captab Ltd undervalued or overvalued?

Innova Captab Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Innova Captab Ltd a good buy now?

Innova Captab Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Innova Captab Ltd?

Innova Captab Ltd revenue growth is 10.8% for FY-2025, which is below its 5-year CAGR of 20.74%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Innova Captab Ltd?

Innova Captab Ltd Return on capital employed is 11.6% for FY-2025, which is below its 5-year historical median of 21.7%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Innova Captab Ltd?

Innova Captab Ltd Return on Asset is 6.98%, which is below its 5-year historical median of 9.02%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Innova Captab Ltd?

Innova Captab Ltd Return on equity is 11.64% for FY-2025, which is below its 5-year historical median of 24.02%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Innova Captab Ltd?

Innova Captab Ltd Cash conversion cycle is 60 days, in line with its 5-year historical median of 60 days, indicating stable working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.75	1.32
ROE	11.64	24.02
ROCE	11.6	21.7
Cash Conversion Cycle	60 days	60 days

Q.6 Gross Profit margin of Innova Captab Ltd?

Innova Captab Ltd Gross profit margin which is the profit after deduction of direct costs, is 14.3% for FY-2025, which is above its 5-year median of 12.2%, indicating increasing margins.

Q.7 Operating Profit Margin of Innova Captab Ltd?

Innova Captab Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 12.77% for FY-2025, which is in line with its 5-year median of 12.71% indicating stable margins.

Q.8 Net Profit Margin of Innova Captab Ltd?

Innova Captab Ltd Net Profit Margin is 9.34% for FY-2025, is above with its 5-year median of 8.4%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	14.3	12.2
Operating Profit Margin	12.77	12.71
Net Profit Margin	9.34	8.4

Q.9 Debt to Equity ratio of Innova Captab Ltd?

Innova Captab Ltd Debt-to-Equity ratio is 0.40, which is above with the industry average of 0.27, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Innova Captab Ltd?

Innova Captab Ltd Debt to cash flow from operations is 16.52, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Innova Captab Ltd?

Promoters hold 50.90% of the Innova Captab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Innova Captab Ltd vs industry peers?

Innova Captab Ltd revenue CAGR is 20.74%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	10.8	8.3
Gross Profit Growth	30.5	14.7
Operating Profit Growth	13	11.4
Net Profit Growth	30.9	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.75	0.81
ROE	11.64	9.49
ROCE	11.6	11.91
Cash Conversion Cycle (days)	60.24	85

Valuation & price assessment

Q.1 Stock return of Innova Captab Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -14.85% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-	-14.9%

Q.3 Valuation ratios of Innova Captab Ltd vs historical?

The current P/E is similar that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	53.96	53.91	31.09
Price to Book	4.9	5.27	2.85
Price to Sales	3.63	4.53	2.79
EV to EBITDA	29.24	33.41	15.87

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Capri Global Capital Ltd.

2. IIFL Finance Ltd.

3. Mahindra & Mahindra Financial Services Ltd.

4. JSW Infrastructure Ltd.

5. L&T Finance Ltd.